Veterinary and Human Medical Centers Collaborate
Combined approach offers new treatments for dogs with naturally occurring diseases.
News Item by Mary Straus, published in the Whole Dog Journal, May 2011
The Virginia-Maryland Regional College of Veterinary Medicine and Wake Forest University’s Institute for Regenerative Medicine in Winston-Salem, North Carolina, signed an agreement in January to form the Virginia Tech/Wake Forest Center for Veterinary Regenerative Medicine (CVRM).
The goal is to facilitate the use of cutting-edge, regenerative (stem cell) treatments for pets and people. Clinical trials performed at the center will provide valuable information concerning the effects of stem-cell therapy, which has relied mostly on anecdotal reports in the past. Doctors will be able to evaluate the results as a model for the treatment of similar diseases in humans.
As part of the collaboration, clients at the Veterinary Teaching Hospital may have the option to enter their pets into clinical trials, giving them access to cutting-edge technology unavailable elsewhere.
Current areas of interest for this research include cardiomyopathy and spay-induced incontinence in dogs, chronic kidney disease in cats, and wound healing in horses. Let’s hope they also investigate the use of regenerative stem cell therapy in the treatment of arthritis, where preliminary results seem promising.
There are many potential applications for collaboration between human and veterinary medicine. In March, I wrote about a veterinary surgeon, a veterinary endocrinologist, and a neurosurgeon at Cedars-Sinai Medical Center in Los Angeles who worked together and developed a new surgical technique for treating pituitary tumors that cause Cushing’s disease in dogs (New Treatment for Pituitary-Dependent Cushing’s Disease). In September, 2009, I wrote about a treatment for brain tumors that was the result of two comparative oncology specialists working together, one a veterinary surgeon and the other the head of his university’s Neurosurgery Gene Therapy Program (New Therapy for Brain Cancer). Bone marrow transplants for dogs with lymphoma use the same leukaphoresis machines to harvest healthy stem cells from dogs as from people (Marrow Transplants Promising for Treating Canine Lymphoma, October 2010).
I applaud this approach to finding new treatments for pets and people. It is so much better to offer clinical trials for pets with diseases that cannot be effectively treated with today’s methodologies, rather than induce illness in laboratory animals in order to try out new treatments. I hope this center becomes a model for other veterinary schools.
You can contact me if you have any comments, but I regret to say that I can no longer respond to questions about individual dogs. See my Contact page for more information. My name is Mary Straus and you can email me at either or